Kiomedine VS One

The first and only innovative treatment based on CM-Chitosan for the symptomatic treatment of Knee Osteoarthritis.
Kiomedine is a new patented technology administered as single shot with extremely positive results in the management of Osteoarthritis.

Key Advantages:

- Kiomedine is a single injection treatment that lasts for a minimum of 6 months.
- Unsurpassed results based on dual mechanism of action, through enhancement of lubrication and protection of endogenous Synovial components.
- Compared to traditional knee injections, Kiomedine showed statistically significant difference in terms of Knee co-efficient of friction, mobility and scavenging anti-oxidative action